Has Sulada Kanchana, MD received payments from drug or device companies?

Yes. Drug and device makers reported $852 in general payments to Sulada Kanchana, MD across 18 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sulada Kanchana, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sulada Kanchana, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sulada Kanchana, MD

Neurology · Poughkeepsie, NYNPI 1538137773

Payments from drug & device makers

$852in general payments, 2019–2025

Across 18 payments — averaging $47.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Acadia Pharmaceuticals Inc$247
Medtronic$163
Boston Scientific$151
Kyowa Kirin, Inc.$126
AbbVie$41
Revance Therapeutics, Inc.$37
plus $88 from 4 others

What the payments were for

Travel & lodging$324%
Food & beverage$82096%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Acadia Pharmaceuticals Inc	2	$247
Medtronic(2 entities)	5	$163
Boston Scientific	2	$151
Kyowa Kirin, Inc.	2	$126
AbbVie	2	$41
Revance Therapeutics, Inc.	1	$37
Merz Pharmaceuticals, LLC	1	$30
Bioventus LLC	1	$25
Tanabe Pharma America, Inc.	1	$18
Adamas Pharmaceuticals, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$852 in reported general payments places this provider in the 40th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024

$69,947

Medicare patients

229

Services billed

3,870

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Rasagiline Mesylate	20	$2,807
Carbidopa-LevodopaCarbidopa/Levodopa	143	$2,019
Carbidopa-Levodopa ErCarbidopa/Levodopa	30	$1,508
Primidone	15	$1,006
Donepezil Hcl	30	$213
Levetiracetam	12	$211
Gabapentin	22	$209
Mirtazapine	12	$184
Topiramate	18	$85

Paid to pharmacies, not to this prescriber.

Other neurology in Poughkeepsie

Christian GrommesNew York$9.9M
Ilya KisterNew York$9.5M
E DorseyNew York$8.5M
Lauren SchaffNew York$8.2M
Richard HolubAlbany$6.3M
Martin SadowskiNew York$5.4M
Lawrence HonigNew York$4.9M
Laszlo MechtlerAmherst$4.3M
Bennett MyersAmherst$3.8M
Krupa PandeyAlbany$3.8M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →